New York University, J.D., cum laude, 1997
Wake Forest University, B.A., summa cum laude, 1993, Phi Beta Kappa
Scott Dove’s transactional and corporate practice covers a range of commercial transactions, with a focus on private equity acquisitions and dispositions, other mergers and acquisitions, health care investments and joint ventures, real estate joint ventures and debt financings. He has represented a variety of public and private companies and private equity groups in numerous industries, including telecom, health care, real estate and insurance.
Scott's acquisition and disposition work has focused primarily on private equity investments in, and dispositions of, portfolio companies, including control acquisitions, minority investments and bolt-on acquisitions for existing portfolio companies. He has extensive experience in structuring both the purchase/sale documents and the related equity and financing agreements. Scott represented a private company in connection with a $2.3 billion recapitalization involving an amendment to existing credit facilities and an investment by a Canadian pension fund.
Scott is actively involved in working with health systems, service providers and physicians in a variety of investment and joint venture transactions. He has advised on dozens of dialysis and vascular access joint venture transactions. Scott also represents many real estate developers in joint venture transactions.
Scott serves on Robinson Bradshaw's board of directors and as co-chair of the firm's Corporate Department.
Advises holding company and its craft brewery and distillery subsidiaries in connection with general corporate matters and contract negotiations.
Represented a private equity group in the acquisition of multiple portfolios of wireless telecom sites.
Represented a large physician practice in a corporate reorganization.
Represented a private equity group in both its acquisition and capitalization and subsequent disposition of an aggregator of wireless telecom easements, involving management rollover equity, co-investment equity and new senior debt as components of the capitalization.
Represented a private equity group in both its acquisition and capitalization of a craft brewery and distillery, involving management rollover equity, co-investment equity, new incentive equity and senior debt financing as components of the capitalization.
Represented a private equity group in the acquisition of a portfolio of venture capital loans, involving management rollover equity and co-investment equity as components of the capitalization.
Represented a public company provider of kidney dialysis services in the $385 million acquisition of a national vascular access center company.
Represented a private company in the insurance sector in the sale of a North Carolina auto insurance company.
Represented a health system in a long-term management contract with a physician practice.
News & Events
- June 26, 2018
- June 25, 2018
- April 30, 2018
- April 24, 2018
- Eight Named “Lawyer of the Year”Aug. 16, 2017
- Eight Attorneys Named "Lawyer of the Year"Aug. 15, 2016
- June 14, 2016
- Aug. 18, 2015
- Firm Topped North Carolina Rankings in Eight Practice AreasAug. 19, 2014
- Robinson Bradshaw noted in AmLaw Daily article on "Four Firms Advise as Fresenius Spends $2 Billion on Dialysis Centers"Aug. 2, 2011
- Forty-Six Robinson Bradshaw Attorneys Named North Carolina Super Lawyers, North Carolina Rising Stars for 2010Jan. 28, 2010